Glenn Jaffe
Ophthalmology Residency · Duke University Hospital
Credentials: · ·
History
2024–Present- 2023–2024
Research
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
New England Journal of Medicine · 2011 · Last of 7 authors · 2,218 citations
Ophthalmology · 2012 · 1,482 citations
Ophthalmology · 2018 · 802 citations
39 papers · 1 as a fellow
38 papers · 3 as a fellow
36 papers
18 papers
17 papers · 4 as a fellow
17 papers
- EC
16 papers
- FF
16 papers
Grants
- 2022–2027
National Eye Institute · UG1
Contact PI · $1.3M · Duke University
- 2006–2013
Comparison of AMD Treatment Trials-OCT Reading Center
National Eye Institute · U10
Contact PI · $2.3M · Duke University
- 1992–2006
Cytokine Modulation in Proliferative Vitreoretinopathy
National Eye Institute · R01
Contact PI · $1.9M · Duke University
- 1998–2002
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $843K · Duke University
Clinical trials
- 2013–2018
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Principal investigator · Completed · Phase 3
EyePoint Pharmaceuticals, Inc.
- 2012–2018
Principal investigator · Completed · Phase 1
Glenn Jaffe
- 2007–2008
Diagnostic Yield of Vitreous Biopsy in Sarcoid Uveitis
Principal investigator · Completed
Duke University
- 2006–2008
Retisert and Cataract Surgery in Patients With Severe Uveitis
Principal investigator · Completed
Duke University